Pfizer says its vaccine targeting Omicron will be ready in March
Companies, agencies, institutions, etc
Watch CBSN Live
Omicron
Pfizer
COVID-19
CNBC
the Centers for Disease Control and Prevention
BioNTech
CBS MoneyWatch
White House
the U.K. Health Security Agency
Moderna
Goldman Sachs' Healthcare
Bancel
J.P. Morgan's
Breaking News & Analysis
the Free CBS News
CBS Interactive Inc.
ICE Data Services
FactSet
The Associated Press.
People
Megan Cerullo
Albert Bourla
Anthony Fauci
shot."Given
Stéphane Bancel
Groups
COVID-19
Americans
Physical locations
No matching tags
Places
No matching tags
Locations
U.S.
Germany
Events
Annual Healthcare Conference
Summary
Pfizer will have a COVID-19 vaccine that specifically targets the Omicron variant ready by March, the pharmaceutical company's chief executive said Monday. A recent study from the U.K. Health Security Agency found that booster shots are up to 75% effective at preventing symptomatic COVID-19 infection caused by Omicron.Moderna on Monday said in an update on its website that while the pharmaceutical firm's first line of defense against Omicron is a third dose of its existing vaccine, it is also developing an Omicron-specific booster shot."Given the long-term threat demonstrated by Omicron's immune escape, Moderna will continue to develop an Omicron-specific variant vaccine," the company said.
As said here by Megan Megan